Literature DB >> 23216424

Does message framing predict willingness to participate in a hypothetical HIV vaccine trial: an application of Prospect Theory.

Michael Evangeli1, Zuhayr Kafaar, Ashraf Kagee, Leslie Swartz, Philippa Bullemor-Day.   

Abstract

It is vital that enough participants are willing to participate in clinical trials to test HIV vaccines adequately. It is, therefore, necessary to explore what affects peoples' willingness to participate (WTP) in such trials. Studies have only examined individual factors associated with WTP and not the effect of messages about trial participation on potential participants (e.g., whether losses or gains are emphasized, or whether the outcome is certain or uncertain). This study explores whether the effects of message framing on WTP in a hypothetical HIV vaccine trial are consistent with Prospect Theory. This theory suggests that people are fundamentally risk averse and that (1) under conditions of low risk and high certainty, gain-framed messages will be influential (2) under conditions of high risk and low certainty, loss-framed messages will be influential. This cross-sectional study recruited 283 HIV-negative students from a South African university who were given a questionnaire that contained matched certain gain-framed, certain loss-framed, uncertain gain-framed, and uncertain loss-framed statements based on common barriers and facilitators of WTP. Participants were asked to rate how likely each statement was to result in their participation in a hypothetical preventative HIV vaccine trial. Consistent with Prospect Theory predictions, for certain outcomes, gain-framed messages were more likely to result in WTP than loss-framed messages. Inconsistent with predictions, loss-framed message were not more likely to be related to WTP for uncertain outcomes than gain-framed messages. Older students were less likely to express their WTP across the different message frames. Recruitment for HIV vaccine trials should pay attention to how messages about the trial are presented to potential participants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23216424     DOI: 10.1080/09540121.2012.748163

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  10 in total

1.  Does perceived risk influence the effects of message framing? A new investigation of a widely held notion.

Authors:  Jonathan Van 't Riet; Anthony D Cox; Dena Cox; Gregory D Zimet; Gert-Jan De Bruijn; Bas Van den Putte; Hein De Vries; Marieke Q Werrij; Robert A C Ruiter
Journal:  Psychol Health       Date:  2014-03-27

2.  The Effect of Message Framing on African American Women's Intention to Participate in Health-Related Research.

Authors:  Joyce E Balls-Berry; Sharonne Hayes; Monica Parker; Michele Halyard; Felicity Enders; Monica Albertie; Vivian Pinn; Carmen Radecki Breitkopf
Journal:  J Health Commun       Date:  2016-04-14

3.  Health Communication and Decision Making about Vaccine Clinical Trials during a Pandemic.

Authors:  Aisha T Langford
Journal:  J Health Commun       Date:  2020-10-02

4.  Who Aren't We Reaching? Young Sexual Minority Men's Non-participation in an HIV-Prevention and Mental Health Clinical Trial.

Authors:  Audrey Harkness; Brooke G Rogers; Raymond Balise; Daniel Mayo; Elliott R Weinstein; Steven A Safren; John E Pachankis
Journal:  AIDS Behav       Date:  2021-01-23

5.  A formative evaluation of social media campaign to reduce adolescent dating violence.

Authors:  Danielle N Lambert; Lauren E Bishop; Stephanie Guetig; Paula M Frew
Journal:  JMIR Res Protoc       Date:  2014-11-12

6.  Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.

Authors:  Yuan Dong; Xiaoxing Shen; Ruizhang Guo; Baochi Liu; Lingyan Zhu; Jing Wang; Linxia Zhang; Jun Sun; Xiaoyan Zhang; Jianqing Xu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

7.  "Why Don't You Go Into Suburbs? Why Are You Targeting Us?": Trust and Mistrust in HIV Vaccine Trials in South Africa.

Authors:  Siyabonga Thabethe; Catherine Slack; Graham Lindegger; Abigail Wilkinson; Douglas Wassenaar; Philippa Kerr; Linda-Gail Bekker; Kathy Mngadi; Peter A Newman
Journal:  J Empir Res Hum Res Ethics       Date:  2018-12       Impact factor: 1.742

8.  The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Authors:  Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf
Journal:  Trop Med Int Health       Date:  2019-01-08       Impact factor: 2.622

9.  Willingness to Participate and Associated Factors in a Zika Vaccine Trial in Indonesia: A Cross-Sectional Study.

Authors:  Harapan Harapan; Mudatsir Mudatsir; Amanda Yufika; Yusuf Nawawi; Nur Wahyuniati; Samsul Anwar; Fitria Yusri; Novi Haryanti; Nanda Putri Wijayanti; Rizal Rizal; Devi Fitriani; Nurul Fadhliati Maulida; Muhammad Syahriza; Ikram Ikram; Try Purwo Fandoko; Muniati Syahadah; Febrivan Wahyu Asrizal; Kurnia F Jamil; Yogambigai Rajamoorthy; Abram Luther Wagner; David Alexander Groneberg; Ulrich Kuch; Ruth Müller; R Tedjo Sasmono; Allison Imrie
Journal:  Viruses       Date:  2018-11-18       Impact factor: 5.048

10.  Education and Message Framing Increase Willingness to Undergo Research Lumbar Puncture: A Randomized Controlled Trial.

Authors:  Megan G Witbracht; Olivia M Bernstein; Vanessa Lin; Christian R Salazar; S Ahmad Sajjadi; Dan Hoang; Chelsea G Cox; Daniel L Gillen; Joshua D Grill
Journal:  Front Med (Lausanne)       Date:  2020-09-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.